Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the American Chemical Society

• Publication date

  2009-01-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ja806062gPMID 19133767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards improving compound selection in structure-based virtual screening.

  2008cited by this paper
• Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.

  2008cited by this paper
• Amyloid imaging in Alzheimer's disease.

  2008cited by this paper
• Rotamerism, tautomerism, and excited-state intramolecular proton transfer in 2-(4'-N,N-diethylamino-2'-hydroxyphenyl)benzimidazoles: novel benzimidazoles undergoing excited-state intramolecular coupled proton and charge transfer.

  2008cited by this paper
• Congo red and thioflavin-T analogs detect Abeta oligomers.

  2008cited by this paper
• Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

  2008cited by this paper
• Metals in Alzheimer's and Parkinson's diseases.

  2008cited by this paper
• Quantification of the binding constant of copper(II) to the amyloid-beta peptide.

  2008cited by this paper
• Thioflavin Derivatives as Markers for Amyloid‐β Fibrils: Insights into Structural Features Important for High‐Affinity Binding

  2008cited by this paper
• Redox Silencing of Copper in Metal-linked Neurodegenerative Disorders

  2007cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.

  2007cited by this paper
• Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

  2007cited by this paper
• Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

  2007cited by this paper
• In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies

  2007cited by this paper
• Binding of Proteases to Fibrillar Amyloid-β Protein and its Inhibition by Congo Red

  2007cited by this paper
• Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.

  2007cited by this paper
• The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease

  2007cited by this paper
• Congo red and thioflavin‐T analogs detect Aβ oligomers

  2007cited by this paper
• Styryl‐Based Compounds as Potential in vivo Imaging Agents for β‐Amyloid Plaques

  2007cited by this paper
• Therapeutic treatments for Alzheimer's disease based on metal bioavailability.

  2006cited by this paper
• On the intramolecular proton transfer of 3-hydroxyflavone in the first singlet excited state: A theoretical study

  2006cited by this paper
• Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease

  2006cited by this paper
• Phenoxyl radicals: H-bonded and coordinated to Cu(II) and Zn(II).

  2006cited by this paper
• In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind”

  2005cited by this paper
• Amyloid-β Metal Interaction and Metal Chelation

  2005cited by this paper
• Syntheses, structures, photoluminescence, and theoretical studies of a class of beryllium(II) compounds of aromatic N,O-chelate ligands.

  2005cited by this paper
• The binding of thioflavin-T to amyloid fibrils: localisation and implications.

  2005cited by this paper
• Amyloid-beta metal interaction and metal chelation.

  2005cited by this paper
• A new strategy to combat Alzheimer's disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule.

  2005cited by this paper
• The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.

  2004cited by this paper
• Novel technologies for virtual screening.

  2004cited by this paper
• PET imaging of amyloid in Alzheimer's disease.

  2004cited by this paper
• Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimers Disease

  2004cited by this paper
• Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

  2004cited by this paper
• Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases.

  2004cited by this paper
• 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.

  2004cited by this paper
• Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies.

  2004cited by this paper
• Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study.

  2003cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• Chemical substructures in drug discovery.

  2003cited by this paper
• Structures, electronic states, and electroluminescent properties of a zinc(II) 2-(2-hydroxyphenyl)benzothiazolate complex.

  2003cited by this paper
• Current Status of Metals as Therapeutic Targets in Alzheimer's Disease

  2003cited by this paper
• The galvanization of β-amyloid in Alzheimer's disease

  2002cited by this paper
• Metal complexing agents as therapies for Alzheimer's disease.

  2002cited by this paper
• ACIDITY OF SOME 2-SUBSTITUTED-1HBENZIMIDAZOLES AND THEIR AFFINITY TOWARDS Cu(II) ION

  2001cited by this paper
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

  2001cited by this paper
• A phenoxyl radical complex of copper(II).

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Structural studies of soluble oligomers of the alzheimer β-amyloid peptide

  2000cited by this paper
• Role of rotamerisation and excited state intramolecular proton transfer in the photophysics of 2-(2′-hydroxyphenyl)benzoxazole, 2-(2′-hydroxyphenyl)benzimidazole and 2-(2′-hydroxyphenyl)benzothiazole: a theoretical study

  2000cited by this paper
• Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.

  2000cited by this paper
• Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

  2000cited by this paper
• Excited-State Intramolecular Proton Transfer in 2-(2‘-Acetamidophenyl)benzimidazole

  2000cited by this paper
• Amyloid fibril formation from full-length and fragments of amylin.

  2000cited by this paper
• Computational methods for the prediction of 'drug-likeness'

  2000cited by this paper
• 3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl- 4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity

  2000cited by this paper
• 3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1H)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity.

  2000cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species

  1999cited by this paper
• Theoretical Evaluation of Solvent Effects on the Conformational and Tautomeric Equilibria of 2-(2'-Hydroxyphenyl)benzimidazole and on Its Absorption and Fluorescence Spectra

  1999cited by this paper
• Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.

  1999cited by this paper
• EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER IN 2-(2'-AMINOPHENYL) BENZIMIDAZOLE

  1998cited by this paper
• Virtual screening : an overview

  1998cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• An efficient implementation of time-dependent density-functional theory for the calculation of excitation energies of large molecules

  1998cited by this paper
• Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.

  1998cited by this paper
• Synthesis and Coordination Chemistry of the Bis(imidazole) Ligand, Bis(1-methyl-4,5-diphenylimidaz-2-oyl)(benzyloxy)methane.

  1997cited by this paper
• CALCULATION OF EXCITATION ENERGIES WITHIN TIME-DEPENDENT DENSITY FUNCTIONAL THEORY USING AUXILIARY BASIS SET EXPANSIONS

  1997cited by this paper
• Efficient Reagents for the Synthesis of 5-, 7-, and 5,7-Substituted Indoles Starting from Aromatic Amines: Scope and Limitations

  1996cited by this paper
• H-Atom Transfer and Rotational Processes in the Ground and First Singlet Excited Electronic States of 2-(2‘-Hydroxyphenyl)oxazole Derivatives: Experimental and Theoretical Studies†

  1996cited by this paper
• Thioflavine T interaction with amyloid β-sheet structures

  1995cited by this paper
• Density-functional thermochemistry. III. The role of exact exchange

  1993cited by this paper
• Acid-mediated reaction of bis(pyridine)iodonium(I) tetrafluoroborate with aromatic compounds. A selective and general iodination method

  1993cited by this paper
• Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

  1988cited by this paper
• Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes.

  1987cited by this paper
• Cooperative aspects of hydrogen bonding in carbohydrates

  1978cited by this paper
• Spectroscopic and redox properties of pseudotetrahedral copper(II) complexes. Their relation to copper proteins

  1977cited by this paper
• Gaussian basis sets for molecular calculations. The representation of 3d orbitals in transition‐metal atoms

  1977cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper
• The Crystal Structure of 2-(o-Hydroxyphenyl)benzothiazole.

  1970cited by this paper
• Gaussian Basis Set for Molecular Wavefunctions Containing Third‐Row Atoms

  1970cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper
• Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

  1962cited by this paper
• Determination of the equivalence point in potentiometric titrations. Part II

  1952cited by this paper

• An overview on copper in industrial chemistry: From ancient pigment to modern catalysis

  2025cites this paper
• Antioxidant activity at the molecular level: exploring ways of action and computational tools to investigate them

  2025cites this paper
• Recent advances in the synthesis of Glycoconjugated heterocycles: A promising strategy for accessing bioactive compounds.

  2025cites this paper
• Recent advances in zirconium-based catalysis and its applications in organic synthesis: a review

  2025cites this paper
• Power of Dopamine: Multifunctional Compound Assisted Conversion of the Most Risk Factor into Therapeutics of Alzheimer's Disease.

  2024cites this paper
• Heterocyclic Scaffolds Bearing –N=N- Moiety: Recent Advances in the Synthesis of Heterocyclic Azo-Dispersive Dyes

  2024cites this paper
• The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review

  2024cites this paper
• Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

  2024cites this paper
• Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules.

  2024cites this paper
• Crystal structure of 3-(benzo[d]thiazol-2-yl)-5-bromo-2-hydroxybenzaldehyde, C14H8BrNO2S

  2024cites this paper
• Interaction studies of oxindole-derivatives with β-amyloid peptides inhibiting its aggregation induced by metal ions.

  2023cites this paper
• Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease

  2023cites this paper
• Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights

  2023cites this paper
• Synthesis and Application of Novel Nanomagnetic Catalyst Fe_3O_4@SiO_2@Pr–Gu–Cr–COOH in the Green Multi-component Synthesis of 1-(Benzothiazolylamino)methyl-2-naphthol

  2023cites this paper
• Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors

  2023cites this paper
• Early Aggregation of Amyloid-β(1-42) Studied by Fluorescence Correlation Spectroscopy.

  2023cites this paper
• Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils

  2023cites this paper
• Drug Discovery and Amyotrophic Lateral Sclerosis: Emerging Challenges and Therapeutic Opportunities.

  2022cites this paper
• Tailoring the AIE Chromogen 2-(2-Hydroxyphenyl)benzothiazole for Use in Enzyme-Triggered Molecular Brachytherapy

  2022cites this paper
• Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease

  2022cites this paper
• An insight into prodrug strategy for the treatment of Alzheimer’s disease

  2022cites this paper
• Synthesis of benzothiazole and benzimidazole derivatives via an eco-friendly method using piperazine immobilized on nano-ZnO-sulfuric acid as a powerful catalyst

  2021cites this paper
• Impact of Cu(II) and Al(III) on the conformational landscape of amyloidβ1-42.

  2021cites this paper
• Ruthenium(ii) p-cymene complexes of pyridine-2-carboxaldehyde and 2-amino benzothiazole-based ligands: cytoselective and in vitro live cell imaging agents

  2021cites this paper
• α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease

  2021cites this paper
• Fe 3 O 4 @MCM‐41@ZrCl 2 : A novel magnetic mesoporous nanocomposite catalyst including zirconium nanoparticles for the synthesis of 1‐(benzothiazolylamino)phenylmethyl‐2‐naphthols

  2021cites this paper
• The Effects of Redox-Active Metal Ions and Amyloid-Degrading Enzymes on the Pathology of Alzheimer's Disease

  2021cites this paper
• Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders

  2021cites this paper
• Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

  2021cites this paper
• Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

  2021cites this paper
• Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy

  2021cites this paper
• Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease.

  2021cites this paper
• Longitudinal Functional Study of Murine Aging: A Resource for Future Study Designs

  2021cites this paper
• Direct Oxygenation of C-H Bonds through Photoredox and Palladium Catalysis.

  2020cites this paper
• Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer’s Disease

  2020cites this paper
• Twisted Schiff-base macrocycle showing excited-state intramolecular proton-transfer (ESIPT): assembly and sensing properties.

  2020cites this paper
• A β-sheet-targeted theranostic agent for diagnosing and preventing aggregation of pathogenic peptides in Alzheimer’s disease

  2020cites this paper
• Recent Advancements on Transition‐Metal‐Catalyzed, Chelation‐Induced ortho ‐Hydroxylation of Arenes

  2020cites this paper
• Multifunctional compounds for the treatment of Alzheimer’s disease

  2020cites this paper
• Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.

  2020cites this paper
• Complexes based N,N-donors (2,2′-bipyridyl & 2-(2-aminophenyl)benzimidazole); Synthesis, characterization, DNA interaction and toxicity assessment against Chlorella vulgaris microchlorophyte; X-ray crystal structure of [Zn(bpy)3)]Cl2

  2020cites this paper
• Engineering of an archaeal phosphodiesterase to trigger aggregation-induced emission (AIE) of synthetic substrates

  2020cites this paper
• Aryldiazoquinoline based multifunctional small molecules for modulating Aβ42 aggregation and cholinesterase activity related to Alzheimer's disease

  2020cites this paper
• The influence of Ca2+ and Zn2+ on the amyloid fibril formation by β-casein.

  2020cites this paper
• Selective Formation of 2‐(2‐Aminophenyl)benzothiazoles via Copper‐Catalyzed Aerobic C−C Bond Cleavage of Isatins

  2020cites this paper
• Synthesis of Phenolic Compounds via Palladium Catalyzed C-H Functionalization of Arenes.

  2019cites this paper
• Straightforward convergent access to 2-arylated polysubstituted benzothiazoles

  2019cites this paper
• Novel dual‐action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine‐specific histone demethylase 1A inhibitor

  2019cites this paper
• Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

  2019cites this paper
• Studying the reactivity of "old" Cu(II) complexes for "novel" anticancer purposes.

  2019cites this paper
• Luminescent bis(benzo[d]thiazolyl)quinoxaline: facile synthesis, nucleic acid and protein BSA interaction, live-cell imaging, biopharmaceutical research and cancer theranostic application

  2019cites this paper
• Thioflavin T: A versatile optical probe for chemo and biosensing

  2019cites this paper
• Rational design of the benzothiazole-based fluorescent scaffold for tunable emission

  2019cites this paper
• Neuroprotection in Alzheimer Disease

  2019cites this paper
• Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments

  2019cites this paper
• Positively Charged Polyprodrug Amphiphiles with Enhanced Drug Loading and Reactive Oxygen Species-Responsive Release Ability for Traceable Synergistic Therapy.

  2018cites this paper
• Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease

  2018cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• Dual-Aptamer-Conjugated Molecular Modulator for Detecting Bioactive Metal Ions and Inhibiting Metal-Mediated Protein Aggregation.

  2018cites this paper
• Modulating Conformation of Aβ-Peptide: An Effective Way to Prevent Protein-Misfolding Disease.

  2018cites this paper
• Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation.

  2018cites this paper
• An overview on ligands of therapeutically interest

  2018cites this paper
• Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies

  2018cites this paper
• Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications.

  2018cites this paper
• Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.

  2018cites this paper
• The mechanism of action of clioquinol for the treatment of Alzheimer's disease

  2018cites this paper
• Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer's agents

  2018cites this paper
• Bifunctionality of Iminodiacetic Acid-Modified Lysozyme on Inhibiting Zn2+-Mediated Amyloid β-Protein Aggregation.

  2018cites this paper
• Synthesis and characterisation of novel phenanthroline quinone derivatives and their evaluation as Alzheimer's disease therapeutic active ingredients

  2018cites this paper
• Evaluation of 64Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease

  2017cites this paper
• Facile synthesis of novel [1,3]oxazino[2,3-c][1,2,4] thiadiazin-12-one derivatives

  2017cites this paper
• Dual antioxidant/pro-oxidant behavior of the tryptophan metabolite 3-hydroxyanthranilic acid: a theoretical investigation of reaction mechanisms and kinetics

  2017cites this paper
• An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases

  2017cites this paper
• Curcumin-like compounds designed to modify amyloid beta peptide aggregation patterns

  2017cites this paper
• Design of Metal Complexes as Anti-AD Agents

  2017cites this paper
• Amberlite IRA 402(OH) Mediated Green Synthesis of Novel Benzothiazole–quinoline Conjugates as Cancer Theranostics

  2017cites this paper
• Structural and Mechanistic Insights into Development of Chemical Tools to Control Individual and Inter-Related Pathological Features in Alzheimer's Disease.

  2017cites this paper
• Nouvelles preuves de concept pour la chélatothérapie contre la maladie d'Alzheimer : études spectroscopiques des interactions entre les ions cuivre et zinc

  2017cites this paper
• Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc01269a Click here for additional data file.

  2017cites this paper
• Computational-aided design of melatonin analogues with outstanding multifunctional antioxidant capacity

  2016cites this paper
• Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease

  2016cites this paper
• Investigation of substitution effect on fluorescence properties of Zn²⁺-selective ratiometric fluorescent compounds: 2-(2'-Hydroxyphenyl)benzimidazole derivatives.

  2016cites this paper
• Ultraviolet irradiation-mediated formation of Aβ42 oligomers and reactive oxygen species in Zn2+-bound Aβ42 aggregates irrespective of the removal of Zn2+

  2016cites this paper
• New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations

  2016cites this paper
• Convenient Approach for the One-Pot, Three-Component Synthesis of 1-(Benzothiazolylamino)Methyl-2- Naphthol Using Citric Acid as a Green Catalyst

  2016cites this paper
• 8-Hydroxyquinolines in medicinal chemistry: A structural perspective.

  2016cites this paper
• Anthranilic acid as a secondary antioxidant: Implications to the inhibition of OH production and the associated oxidative stress

  2016cites this paper
• Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress

  2016cites this paper
• Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.

  2016cites this paper
• Potential Animal Models of Alzheimer Disease and Their Importance in Investigating the Pathogenesis of Alzheimer Disease

  2016cites this paper
• Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease.

  2016cites this paper
• An efficient and green synthesis of novel benzoxazole under ultrasound irradiation.

  2016cites this paper
• Ether-Imine Based Multiresponsive Voltammetric Dipodal Receptor for Nanomolar Detection of Copper Ions

  2016cites this paper
• Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery

  2016cites this paper
• oderate modulation of disease in the G 93 A model of ALS by the ompound 2-( 2-hydroxyphenyl )-benzoxazole ( HBX )

  2016influential citation
• 3-Hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use.

  2015cites this paper
• Coordination properties of a metal chelator clioquinol to Zn(2+) studied by static DFT and ab initio molecular dynamics.

  2015cites this paper
• Optically Triggered Stepwise Double-Proton Transfer in an Intramolecular Proton Relay: A Case Study of 1,8-Dihydroxy-2-naphthaldehyde.

  2015cites this paper
• A Preparation and Spectroscopic Study for Some Copper andOxovanadium Complexes of Enaminones

  2015cites this paper
• Copper-catalyzed cross dehydrogenative coupling of N,N-disubstituted formamides and phenols: a direct access to carbamates

  2015cites this paper